Tag: Ophthalmology

1. Aflibercept 8 mg was non-inferior to 2 mg for best-corrected visual acuity at 48 weeks. 2. Ocular adverse events ...

1. Avacincaptad pegol significantly slowed geographic atrophy over 12 months. 2. Exudative macular neovascularization was comparable among treatment groups. Evidence ...

1. In this retrospective cohort study, the incidence of hydroxychloroquine retinopathy was 2.5% at 10 years, increasing to 8.6% at ...

1. In patients with diabetic macular edema, aflibercept monotherapy showed no difference in vision improvement compared to step therapy of ...

1. In both trials, faricimab was demonstrated to be non-inferior to aflibercept at improving visual acuity in neovascular age-related macular ...

1. Faricimab every 8 weeks and faricimab per personalized treatment interval (PTI) were noninferior to aflibercept for mean change in ...

1. Low-energy FLACS resulted in less endothelial cell count loss post-operatively compared with conventional phacoemulsification. 2. Patients receiving low-energy FLACS ...

1. In this trial, students in grades 3 to 7 who received eyeglasses through a school-based vision program achieved better ...

1. At 24 months, visual quality of life for patients with advanced open angle glaucoma was similar if treated initially ...

Cardiovascular safety of hydroxychloroquine in veterans with rheumatoid arthritis 1. Among a large, matched cohort of veterans with rheumatoid arthritis, ...